The American Cancer Society Cancer Action Network (ACS CAN) is calling on the Senate to change course regarding tobacco control funding in the budget. In the Senate’s budget substitute bill released last week, tobacco prevention and cessation funding was cut in half from the current year funding level of $14.5 million to $7.5 million yearly, which would have a devastating impact on our state's health and economic well-being.
ALBANY, NY – JUNE 9, 2023 – Late last night, the New York State Assembly passed Assembly Bill 1673a to increase access to biomarker testing, which can help determine the best treatment plan for each patient.
Today, lawmakers voted to reauthorize Medicaid expansion in New Hampshire, ensuring thousands of Granite Staters have access to the affordable healthcare they need. The vote is particularly poignant for the dozens of cancer patients and survivors who lobbied for passage of this legislation as June marks Cancer Survivors Month.
Today, Gov. Kevin Stitt signed legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing. Senate Bill 513 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.
Today, the Supreme Court of the United States (SCOTUS) issued a decision in the case of Health and Hospital Corportation of Marion County v. Talevski siding with the plaintiff and ruling that individuals could enforce their civil rights to spending clause programs such as Medicaid via Section 1983.
Today, the U.S. House of Representatives and the U.S. Senate introduced the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act, a bill which would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2028. For more than 30 years, the NBCCEDP has effectively provided critical breast and cervical cancer screenings, follow-up, diagnosis and treatment to lower income, uninsured and underinsured women.
LAS VEGAS, NEV. – The Nevada State Legislature passed Assembly Bill 155 as the 82nd legislative session adjourned, Monday. The bill establishes provisions for biomarker testing in Nevada but falls short of ensuring broader patient access to needed testing. While the American Cancer Society Cancer Action Network (ACS CAN) appreciates lawmakers’ recognition of the growing importance of biomarker testing in the treatment of cancer and other conditions, this bill was significantly weakened from its original intent.
ALBANY, NY – JUNE 5, 2023 – This afternoon, the New York State Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.
Tonight, the Senate passed a debt ceiling deal (HR 3746) by a 63-36 vote and it now heads to the President for his signature.
Earlier this evening, the Rhode Island Senate voted in unanimous support of Senate Bill S799. This legislation would ensure Rhode Islanders receive the total value of prescription drug assistance available to them, improving affordable access to care for many with prescription drug needs